| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.055 | 0.3 |